This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
Europe's premier partnering event
Save the date for next yearNovember 3–5, 2025 | Vienna, Austria

Nick Williams
Partner at Medicxi
Speaker

Profile

Nick is a Partner at Medicxi and joined the firm in 2018. He led Medicxi's investment in Phathom Pharmaceuticals (NASDAQ:PHAT) and currently serves on the boards of a number of portfolio companies, including Altesa Biosciences, Ethyreal Bio and Podium Bio.

Nick's prior investments include MiroBio (acquired by Gilead Sciences) and Versanis Bio (acquired by Eli Lilly).

Nick graduated with an MPharm from Cardiff University and completed his training at St George's Hospital, London before returning to Cardiff to receive his PhD in urological drug delivery.

Agenda Sessions

  • “Money Money Money”: Building a robust venture ecosystem for the next generation of innovations

    15:30